Announcements Trials

Browse Landscape

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thromboembolism 1 Neoplasms 1 Embolism 1

Interventions

Blood Specimen Collection 53 Surveys and Questionnaires 49 Specimen Handling 29 Observation 15 Radiotherapy 14 Magnetic Resonance Spectroscopy 12 Surgical Procedures, Operative 11 Interviews as Topic 11 Data Collection 11 Drug Therapy 9 darolutamide 8 Biopsy 8 palbociclib 7 Watchful Waiting 7 Tomography, X-Ray Computed 7 Standard of Care 7 ribociclib 6 Magnetic Resonance Imaging 6 Bevacizumab 6 trastuzumab deruxtecan 5 Ultrasonography 5 Restraint, Physical 5 Radiofrequency Ablation 5 Patient Reported Outcome Measures 5 Mental Status and Dementia Tests 5 Mastectomy, Segmental 5 Mass Screening 5 Genetic Testing 5 Breath Tests 5 enzalutamide 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Dabigatran × 90 days × Clear all

NCT04618913 2026-05-26

VICTORIE

Pfizer

Active not recruiting

Classical hematology

Embolism, Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡